Your browser doesn't support javascript.
loading
Microbiome Characteristics in Early Threatened Miscarriage Study (MCETMS): a study protocol for a prospective cohort investigation in China.
Chen, Xiaofeng; Guo, Yinan; Zhang, Yingxuan; Si, Chen; Zhang, Huimin; Huang, Xuge; Luo, Songping; Deng, Gaopi; Gao, Jie.
Afiliação
  • Chen X; Department of Gynecology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
  • Guo Y; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Zhang Y; Department of Gynecology, Xi'an Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi Province, China.
  • Si C; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Zhang H; Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Huang X; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Luo S; Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Deng G; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Gao J; Guangzhou University of Chinese Medicine, Guangzhou, China.
BMJ Open ; 12(9): e057328, 2022 09 01.
Article em En | MEDLINE | ID: mdl-36581976
INTRODUCTION: Studies have suggested that the vaginal microbiome and gut microbiome are involved in pregnancy-related diseases, but little exploration of the link with early miscarriage or threatened miscarriage (TM) has been done. Whether the characteristics of the vaginal microbiome and gut microbiome in early pregnancy are related to TM and early pregnancy outcomes remains unclear. METHODS AND ANALYSIS: The Microbiome Characteristics in Early Threatened Miscarriage Study (MCETMS) is a prospective investigation that will recruit 326 pregnant women with early TM. Pregnant women will be enrolled at 4-8 weeks of gestation, and their vaginal secretions, faecal samples, clinical data and sociodemographic characteristics will be collected prospectively. Pregnant women with TM will be followed up to 12 weeks of gestation to determine the early pregnancy outcomes (ongoing pregnancy or pregnancy loss). DNA will be extracted from the collected samples and will be analysed by 16S rRNA gene sequencing. ETHICS AND DISSEMINATION: The MCETMS study protocol has been approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Traditional Chinese Medical University (ZYYECK[2020]051). Dissemination of study findings will occur through peer-reviewed journals, conferences and presentations. TRIAL REGISTRATION NUMBER: ChiCTR2000041172.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Aborto Espontâneo / Ameaça de Aborto / Microbiota Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Aspecto: Ethics Limite: Female / Humans / Pregnancy País/Região como assunto: Asia Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Aborto Espontâneo / Ameaça de Aborto / Microbiota Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Aspecto: Ethics Limite: Female / Humans / Pregnancy País/Região como assunto: Asia Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article